BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/8/2015 8:14:00 AM | Browse: 666 | Download: 1975
Publication Name World Journal of Nephrology
Manuscript ID 15309
Country Greece
ISSN 2220-6124 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Minireviews
Article Title Erectile dysfunction in chronic kidney disease: From pathophysiology to management
Manuscript Source Invited Manuscript
All Author List Eirini Papadopoulou, Anna Varouktsi, Antonios Lazaridis, Chrysoula Boutari and Michael Doumas
Funding Agency and Grant Number
Corresponding Author Michael Doumas, Associate Professor, 2nd Propaedeutic Department of Internal Medicine, Aristotle University, 49 Konstantinoupoleos street, 54643 Thessaloniki, Greece. michalisdoumas@yahoo.co.uk
Key Words Chronic kidney disease; Erectile dysfunction; Management; Quality of life; Hypertension; Diabetes mellitus; Phosphodiesterase-5 inhibitors
Core Tip Erectile dysfunction is highly prevalent among patients with chronic kidney disease in rates that reach even 70%, especially in those suffering from end stage renal disease. The rates of patients suffering from sexual dysfunction tend to be higher when additional risk factors, such as coronary artery disease, diabetes mellitus, hypertension or prescription of antihypertensive drugs, coexist. Integrated management of these patients through lifestyle measures, hormonal replacement, and use of drugs such as phosphodiesterase-5 inhibitors, is essential in order to improve sexual function among these patients, thereby maintaining a satisfactory quality of life.
Publish Date 2015-07-06 18:45
Citation Papadopoulou E, Varouktsi A, Lazaridis A, Boutari C, Doumas M. Erectile dysfunction in chronic kidney disease: From pathophysiology to management. World J Nephrol 2015; 4(3): 379-387
URL http://www.wjgnet.com/2220-6124/full/v4/i3/379.htm
DOI http://dx.doi.org/10.5527/wjn.v4.i3.379
Full Article (PDF) WJN-4-379.pdf
Full Article (Word) WJN-4-379.doc